Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
| Sales | 210,084 | 210,170 | 196,185 | 203,523 | 202,185 |
| Cost of Goods | 79,548 | 78,274 | 74,675 | 82,740 | 78,651 |
| Gross Profit | 130,536 | 131,896 | 121,510 | 120,783 | 123,534 |
| Operating Expenses | 111,348 | 114,149 | 104,718 | 113,774 | 105,894 |
| Operating Income | 19,736 | 18,021 | 17,467 | 7,749 | 18,291 |
| Interest Expense | 5,549 | 7,103 | 7,929 | 7,862 | 7,587 |
| Other Income | 69 | 651 | 55 | 489 | 583 |
| Pre-tax Income | 14,256 | 11,569 | 9,593 | 376 | 11,287 |
| Income Tax | 1,045 | 3,055 | 2,900 | -4,184 | 44 |
| Net Income Continuous | 13,211 | 8,514 | 6,693 | 4,560 | 11,243 |
| Net Income | $13,211 | $8,514 | $6,693 | $4,560 | $11,243 |
| EPS Basic Total Ops | 0.23 | 0.15 | 0.12 | 0.09 | 0.20 |
| EPS Basic Continuous Ops | 0.23 | 0.15 | 0.12 | 0.08 | 0.20 |
| EPS Diluted Total Ops | 0.23 | 0.15 | 0.12 | 0.08 | 0.20 |
| EPS Diluted Continuous Ops | 0.23 | 0.15 | 0.12 | 0.08 | 0.19 |
| EBITDA(a) | $33,673 | $31,973 | $30,803 | $21,375 | $31,935 |